These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11822533)

  • 1. Hypertensive left ventricular hypertrophy: pathophysiological and clinical issues.
    Agabiti-Rosei E; Muiesan ML
    Blood Press; 2001; 10(5-6):288-98. PubMed ID: 11822533
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study.
    Olsen MH; Wachtell K; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Lyle PA; Nieminen MS
    J Hum Hypertens; 2006 Jun; 20(6):460-4. PubMed ID: 16572193
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
    Ibsen H; Pedersen OL; Dahlöf B; Kjeldsen SE; Lindholm LH
    Ugeskr Laeger; 2003 Jan; 165(5):456-9. PubMed ID: 12599843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The heart in hypertension].
    Hennersdorf MG; Strauer BE
    Internist (Berl); 2007 Mar; 48(3):236-45. PubMed ID: 17260148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM; Schmieder RE
    Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Left ventricular hypertrophy and cardiovascular risk in hypertension].
    Amabile G
    Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):86-90. PubMed ID: 9772934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertensive heart disease in paced-hearts.
    Eyuboglu M; Kucuk U
    Int J Cardiol; 2016 Nov; 222():1058. PubMed ID: 26522996
    [No Abstract]   [Full Text] [Related]  

  • 8. Left ventricular hypertrophy: an overlooked cardiovascular risk factor.
    Bauml MA; Underwood DA
    Cleve Clin J Med; 2010 Jun; 77(6):381-7. PubMed ID: 20516249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of hypertensive patients with left ventricular hypertrophy].
    Ambrosioni E
    Presse Med; 2002 Oct; 31 Spec No 2():S13-6. PubMed ID: 12355999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertensive heart. Current situation].
    Riazanov AS; Arakeliants AA; Iurenev AP
    Klin Med (Mosk); 2003; 81(6):15-8. PubMed ID: 12875184
    [No Abstract]   [Full Text] [Related]  

  • 11. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.
    Wachtell K; Olsen MH; Dahlöf B; Devereux RB; Kjeldsen SE; Nieminen MS; Okin PM; Papademetriou V; Mogensen CE; Borch-Johnsen K; Ibsen H
    J Hypertens; 2002 Mar; 20(3):405-12. PubMed ID: 11875307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertensive heart disease. How does blood pressure affect left ventricular mass?
    Prisant LM; Houghton JL; Bottini PB; Carr AA
    Postgrad Med; 1994 May; 95(6):59-62, 66-76. PubMed ID: 8170874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrocardiographic findings].
    Nagasawa H; Inoue H
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():176-80. PubMed ID: 16981539
    [No Abstract]   [Full Text] [Related]  

  • 14. Simultaneous cardiac and renal damage in a hypertensive population.
    Ruilope LM
    J Clin Hypertens (Greenwich); 2009 Jun; 11(6):301-2. PubMed ID: 19527319
    [No Abstract]   [Full Text] [Related]  

  • 15. Electrocardiographic strain pattern and cardiovascular prognosis in hypertension.
    Salles GF
    Am J Hypertens; 2007 Sep; 20(9):1005-6. PubMed ID: 17765143
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiovascular morbidity and mortality and electrocardiographic criteria of left ventricular hypertrophy in hypertensive patients treated in primary care].
    Tovillas-Morán FJ; Vilaplana-Cosculluela M; Zabaleta-del-Olmo E; Dalfó-Baqué A; Galcerán JM; Coca A
    Med Clin (Barc); 2010 Sep; 135(9):397-401. PubMed ID: 20816389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ventricular hypertrophy as an expression of hypertensive damage].
    Chiariello M; Betocchi S
    Cardiologia; 1991 Dec; 36(12 Suppl 1):79-84. PubMed ID: 1841809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of preclinical target organ damage in hypertension: left ventricular hypertrophy.
    Rosei EA;
    J Hypertens; 2002 Jan; 20(1):156-8. PubMed ID: 11791040
    [No Abstract]   [Full Text] [Related]  

  • 19. Ventricular arrhythmias in hypertension: in which patients do they occur?
    Mayet J; Shahi M; Poulter NR; Sever PS; Thom SA; Foale RA
    J Hypertens; 1995 Feb; 13(2):269-76. PubMed ID: 7615959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiac failure in hypertensive cardiopathy].
    Verdecchia P
    Ital Heart J; 2000 Jun; 1 Suppl 2():72-7. PubMed ID: 10905132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.